• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effects of oncogenic mutations on the conformational free-energy landscape of EGFR kinase.致癌突变对 EGFR 激酶构象自由能景观的影响。
Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10616-21. doi: 10.1073/pnas.1221953110. Epub 2013 Jun 10.
2
Hierarchical modeling of activation mechanisms in the ABL and EGFR kinase domains: thermodynamic and mechanistic catalysts of kinase activation by cancer mutations.ABL和EGFR激酶结构域激活机制的层次建模:癌症突变激活激酶的热力学和机制催化剂
PLoS Comput Biol. 2009 Aug;5(8):e1000487. doi: 10.1371/journal.pcbi.1000487. Epub 2009 Aug 28.
3
Molecular Dynamics Analysis of Binding of Kinase Inhibitors to WT EGFR and the T790M Mutant.激酶抑制剂与 WT EGFR 和 T790M 突变体结合的分子动力学分析。
J Chem Theory Comput. 2016 Apr 12;12(4):2066-78. doi: 10.1021/acs.jctc.5b01221. Epub 2016 Apr 4.
4
Structural characterization of EGFR exon 19 deletion mutation using molecular dynamics simulation.采用分子动力学模拟对 EGFR 外显子 19 缺失突变进行结构特征分析。
PLoS One. 2019 Sep 19;14(9):e0222814. doi: 10.1371/journal.pone.0222814. eCollection 2019.
5
Structural insight into the binding mechanism of ATP to EGFR and L858R, and T790M and L858R/T790 mutants.揭示 ATP 与 EGFR、L858R,以及 T790M 和 L858R/T790 突变体结合机制的结构见解。
J Biomol Struct Dyn. 2019 Oct;37(17):4671-4684. doi: 10.1080/07391102.2018.1558112. Epub 2019 Jan 11.
6
Altered conformational landscape and dimerization dependency underpins the activation of EGFR by C-4 loop insertion mutations.C-4 环插入突变激活 EGFR 的结构基础:构象变化和二聚化依赖性。
Proc Natl Acad Sci U S A. 2018 Aug 28;115(35):E8162-E8171. doi: 10.1073/pnas.1803152115. Epub 2018 Aug 13.
7
A Mechanistic Study of a Potent and Selective Epidermal Growth Factor Receptor Inhibitor against the L858R/T790M Resistance Mutation.一种针对 L858R/T790M 耐药突变的强效和选择性表皮生长因子受体抑制剂的机制研究。
Biochemistry. 2019 Oct 15;58(41):4246-4259. doi: 10.1021/acs.biochem.9b00710. Epub 2019 Oct 7.
8
Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors.用突变选择性变构抑制剂克服EGFR(T790M)和EGFR(C797S)耐药性。
Nature. 2016 Jun 2;534(7605):129-32. doi: 10.1038/nature17960. Epub 2016 May 25.
9
Binding mechanism of kinase inhibitors to EGFR and T790M, L858R and L858R/T790M mutants through structural and energetic analysis.通过结构和能量分析研究激酶抑制剂与 EGFR 及 T790M、L858R 和 L858R/T790M 突变体的结合机制。
Int J Biol Macromol. 2018 Oct 15;118(Pt B):1948-1962. doi: 10.1016/j.ijbiomac.2018.07.042. Epub 2018 Jul 12.
10
Structural basis for the altered drug sensitivities of non-small cell lung cancer-associated mutants of human epidermal growth factor receptor.非小细胞肺癌相关人类表皮生长因子受体突变体药物敏感性改变的结构基础。
Oncogene. 2013 Jan 3;32(1):27-38. doi: 10.1038/onc.2012.21. Epub 2012 Feb 20.

引用本文的文献

1
A molecular dynamics protocol for rapid prediction of EGFR overactivation and its application to the rare mutations S768I, S768N, D761N.一种用于快速预测表皮生长因子受体(EGFR)过度激活的分子动力学方案及其在罕见突变S768I、S768N、D761N中的应用
Comput Struct Biotechnol J. 2025 Jul 30;27:3370-3378. doi: 10.1016/j.csbj.2025.07.046. eCollection 2025.
2
Enhanced Sampling and Tailored Collective Variables Yield Reproducible Free Energy Landscapes of Beta-1 Adrenergic Receptor Activation.增强采样与定制集体变量产生β-1肾上腺素能受体激活的可重复自由能景观。
J Chem Theory Comput. 2025 Aug 12;21(15):7687-7700. doi: 10.1021/acs.jctc.5c00600. Epub 2025 Jul 28.
3
Conformational Remodeling and Allosteric Regulation Underlying EGFR Mutant-Induced Activation: A Multi-Scale Analysis Using MD, MSMs, and NRI.表皮生长因子受体(EGFR)突变诱导激活背后的构象重塑和变构调节:使用分子动力学(MD)、马尔可夫状态模型(MSMs)和网络松弛指数(NRI)的多尺度分析
Int J Mol Sci. 2025 Jun 27;26(13):6226. doi: 10.3390/ijms26136226.
4
Design and investigation of novel iridoid-based peptide conjugates for targeting EGFR and its mutants L858R and T790M/L858R/C797S: an in silico study.用于靶向表皮生长因子受体(EGFR)及其突变体L858R和T790M/L858R/C797S的新型环烯醚萜基肽缀合物的设计与研究:一项计算机模拟研究
Mol Divers. 2025 Jun;29(3):2517-2541. doi: 10.1007/s11030-024-11007-3. Epub 2024 Oct 19.
5
Absolute Binding Free Energies with OneOPES.利用 OneOPES 计算绝对结合自由能。
J Phys Chem Lett. 2024 Oct 3;15(39):9871-9880. doi: 10.1021/acs.jpclett.4c02352. Epub 2024 Sep 20.
6
Signaling dynamics in coexisting monoclonal cell subpopulations unveil mechanisms of resistance to anti-cancer compounds.共存的单克隆细胞亚群中的信号动力学揭示了对抗癌化合物耐药的机制。
Cell Commun Signal. 2024 Jul 26;22(1):377. doi: 10.1186/s12964-024-01742-3.
7
Drug-resistant EGFR mutations promote lung cancer by stabilizing interfaces in ligand-free kinase-active EGFR oligomers.耐药性 EGFR 突变通过稳定无配体的激酶活性 EGFR 寡聚体中的界面促进肺癌的发生。
Nat Commun. 2024 Mar 19;15(1):2130. doi: 10.1038/s41467-024-46284-x.
8
OneOPES, a Combined Enhanced Sampling Method to Rule Them All.OneOPES,一种一统天下的组合增强采样方法。
J Chem Theory Comput. 2023 Sep 12;19(17):5731-5742. doi: 10.1021/acs.jctc.3c00254. Epub 2023 Aug 21.
9
Gatekeeper mutations activate FGF receptor tyrosine kinases by destabilizing the autoinhibited state.守门基因突变通过破坏自身抑制状态激活 FGFR 酪氨酸激酶。
Proc Natl Acad Sci U S A. 2023 Feb 21;120(8):e2213090120. doi: 10.1073/pnas.2213090120. Epub 2023 Feb 15.
10
Molecular Mechanisms of Carcinogenesis in Pediatric Airways Tumors.小儿气道肿瘤发生的分子机制。
Int J Mol Sci. 2023 Jan 22;24(3):2195. doi: 10.3390/ijms24032195.

本文引用的文献

1
GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation.GROMACS 4:高效、负载均衡和可扩展的分子模拟算法。
J Chem Theory Comput. 2008 Mar;4(3):435-47. doi: 10.1021/ct700301q.
2
Transitions to catalytically inactive conformations in EGFR kinase.EGFR 激酶向催化无活性构象的转变。
Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7270-5. doi: 10.1073/pnas.1220843110. Epub 2013 Apr 1.
3
Architecture and membrane interactions of the EGF receptor.表皮生长因子受体的结构与膜相互作用。
Cell. 2013 Jan 31;152(3):557-69. doi: 10.1016/j.cell.2012.12.030.
4
Conformational coupling across the plasma membrane in activation of the EGF receptor.EGF 受体激活过程中跨质膜的构象偶联。
Cell. 2013 Jan 31;152(3):543-56. doi: 10.1016/j.cell.2012.12.032.
5
Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain.厄洛替尼结合 EGFR 酪氨酸激酶结构域的无活性和活性构象。
Biochem J. 2012 Dec 15;448(3):417-23. doi: 10.1042/BJ20121513.
6
Mechanism of drug efficacy within the EGF receptor revealed by microsecond molecular dynamics simulation.通过微秒分子动力学模拟揭示表皮生长因子受体的药物疗效机制。
Mol Cancer Ther. 2012 Nov;11(11):2394-400. doi: 10.1158/1535-7163.MCT-12-0644-T. Epub 2012 Aug 3.
7
Oncogenic potential is related to activating effect of cancer single and double somatic mutations in receptor tyrosine kinases.致癌潜能与受体酪氨酸激酶中致癌单、双体种系突变的激活效应有关。
Hum Mutat. 2012 Nov;33(11):1566-75. doi: 10.1002/humu.22145. Epub 2012 Jul 16.
8
Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization.致癌突变抵消了 EGFR 激酶的固有无序性,并促进了受体二聚化。
Cell. 2012 May 11;149(4):860-70. doi: 10.1016/j.cell.2012.02.063.
9
Systematic validation of protein force fields against experimental data.系统地验证蛋白质力场与实验数据的一致性。
PLoS One. 2012;7(2):e32131. doi: 10.1371/journal.pone.0032131. Epub 2012 Feb 22.
10
The different flexibility of c-Src and c-Abl kinases regulates the accessibility of a druggable inactive conformation.不同的 c-Src 和 c-Abl 激酶的灵活性调节了可成药的无活性构象的可及性。
J Am Chem Soc. 2012 Feb 8;134(5):2496-9. doi: 10.1021/ja210751t. Epub 2012 Jan 30.

致癌突变对 EGFR 激酶构象自由能景观的影响。

Effects of oncogenic mutations on the conformational free-energy landscape of EGFR kinase.

机构信息

Institute of Structural and Molecular Biology, University College London, London WC1H 0AJ, United Kingdom.

出版信息

Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10616-21. doi: 10.1073/pnas.1221953110. Epub 2013 Jun 10.

DOI:10.1073/pnas.1221953110
PMID:23754386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3696764/
Abstract

Activating mutations in the epidermal growth factor receptor (EGFR) tyrosine kinase are frequently found in many cancers. It has been suggested that changes in the equilibrium between its active and inactive conformations are linked to its oncogenic potential. Here, we quantify the effects of some of the most common single (L858R and T790M) and double (T790M-L858R) oncogenic mutations on the conformational free-energy landscape of the EGFR kinase domain by using massive molecular dynamics simulations together with parallel tempering, metadynamics, and one of the best force-fields available. Whereas the wild-type EGFR catalytic domain monomer is mostly found in an inactive conformation, our results show a clear shift toward the active conformation for all of the mutants. The L858R mutation stabilizes the active conformation at the expense of the inactive conformation and rigidifies the αC-helix. The T790M gatekeeper mutant favors activation by stabilizing a hydrophobic cluster. Finally, T790M with L858R shows a significant positive epistasis effect. This combination not only stabilizes the active conformation, but in nontrivial ways changes the free-energy landscape lowering the transition barriers.

摘要

表皮生长因子受体(EGFR)酪氨酸激酶的激活突变经常在许多癌症中发现。有人提出,其活性和非活性构象之间的平衡变化与其致癌潜能有关。在这里,我们通过使用大规模分子动力学模拟结合平行温度、元动力学和一种最好的可用力场,定量评估了一些最常见的单(L858R 和 T790M)和双(T790M-L858R)致癌突变对 EGFR 激酶结构域构象自由能景观的影响。虽然野生型 EGFR 催化结构域单体主要处于非活性构象,但我们的结果表明,所有突变体都明显向活性构象转变。L858R 突变以牺牲非活性构象为代价稳定活性构象,并使 αC-螺旋僵化。T790M 看门突变体通过稳定疏水性簇有利于激活。最后,L858R 与 T790M 显示出显著的正上位效应。这种组合不仅稳定了活性构象,而且以非平凡的方式改变了自由能景观,降低了跃迁势垒。